A phase II multi-institution study of docetaxel and doxorubicin as induction therapy followed by sequential high dose chemotherapy and CD 34+ selected stem cell support for women with metastatic breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anastrozole; Antineoplastics; Carboplatin; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Etoposide; Filgrastim; Thiotepa
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 May 2013 Biomarkers information updated
- 24 Sep 2005 New trial record.